FCPA Docket: Bio-Rad’s GC whistleblower saga goes on

In today’s news round-up, a California pharmaceutical company is taking an unfair dismissal case to an appeals court, and the lower legislative body of Congress votes to reform the SEC’s whistleblower awards programme.